Covid-19的体外诊断

Covid-19的体外诊断

Covid-19的体外诊断testing has come to demand due to the spread of the deadly virus.分子检测的需求被认为是诊断传染病的黄金标准，已爆炸。虽然这种疾病仍然无线，但这种需求可能会继续增长。Meanwhile, the rush to meet it has already driven four main developments in the IVD industry

The highly contagious nature of this respiratory disease challenges advanced viralCovid-19的体外诊断technologies for rapid, scalable, affordable, and high accuracy testing. There has been a chronic shortage of diagnostics in these countries and a high demand for quality testing equipment. Testing remains a crucial step in controlling the COVID-19 pandemic.

  • Operon Strategist isFDA 510 k process consultanthelps the clients to register SBU (Small Business Unit), if applicable. Take out the testing requirement of the product, creation of the dossier, resolving the queries and after completion of all the activities, the client receives the US FDA 510 k approval.
  • We also assist with the establishment registration and device listings to make suitable the supply of medical devices in the US.

FDA 510 k Clearance & Premarket Approval for Medical Device

Operon Strategist is FDA 510 k process consultant helps the clients to register SBU (Small Business Unit), if applicable. Take out the testing requirement of the product, creation of the dossier, resolving the queries and after completion of all the activities.

联系我们 whatsapp.

虽然这种疾病仍然无线，但这种需求可能会继续增长。Meanwhile, the rush to meet it has already driven four main developments in theCovid-19的体外诊断这可以提示对诊断测试制造商具有长期影响的结构转变。

Diagnostic-test manufacturers are playing a critical role in government efforts to respond to the COVID-19 pandemic. Yet their work to increase theCovid-19的体外诊断is also initiating changes in the industry that could lead not only to greater adoption but also to greater competition.

There are several types of SARS-CoV-2 and in vitro diagnostics for COVID-19 tests:

  • Diagnostic Tests:检测SARS-COV-2病毒部分的测试，可用于诊断SARS-COV-2病毒的感染。这些包括分子试验和抗原测试。
  • 血清学/抗体和其他适应性免疫应答试验：Tests that detect antibodies (for example, IgM, IgG) to the SARS-CoV-2 virus or that measure a different adaptive immune response (such as, T cell immune response) to the SARS-CoV-2 virus. These types of tests cannot be used to diagnose a current infection.
  • Tests for Management of COVID-19 Patients:Beyond tests that diagnose or detect SARS-CoV-2 virus or antibodies, there are also tests that are authorized for use in the management of patients with COVID-19, such as to detect biomarkers related to inflammation. Once patients are diagnosed with COVID-19 disease, these additional tests can be used to inform patient management decisions.

Covid-19案例的立即检测需要广泛的可用性Covid-19的体外诊断控制病毒的快速传播。确定了公共卫生紧急情况，证明了紧急使用授权Covid-19的体外诊断

Types ofCovid-19的体外诊断Testing Kits Available

  • Molecular Assays:这些是Covid-19最广泛采用的诊断测试。分子诊断测定是为了检测对SARS-COV-2病毒非常特异的病毒RNA的存在，这导致Covid-19。聚合酶链反应（PCR）是这些测定中涉及的过程
  • Immunoassays: ELISA (enzyme-linked immunosorbent assays) is a type of immunoassay that has a greater advantage over PCR. Antigens and antibodies are considerably more stable than RNA, thus reducing the chance of false-negative results. Antigens and antibodies are more uniform in sputum and blood samples increasing its testing efficiency. There are nearly 200 immunoassayscurrently in use or in development.

In-Vitro Diagnostics (IVDs) have always been essential in the detection of infectious diseases. A number of molecular assays and immunoassays are in place currently to detect COVID-19 but quality diagnostics that provides faster and accurate test results is the need of the hour.

Baidu